Quality Provider of Generics and Finished Dosage Formulations

About Us

Company Overview

We are a global vertically integrated pharmaceutical company engaged in research and development, manufacture, sale and distribution of prescription and OTC pharmaceutical products, with global presence in more than 50 countries, including United States, Europe, Canada, Japan, Australia and Rest of the World. We offer a wide range of proprietary finished dosage formulation catering to different therapeutic segments, including CVS, CNS, gastro-intestinal, etc. in multiple dosage forms including:

  • Immediate-release oral solids
  • Modified release oral solids
  • MUPS based products
  • Chewable tablets
  • Powder for oral solutions & Suspensions

Jubilant Pharma Limited

Jubilant Generics Limited is a subsidiary of Jubilant Pharma Limited

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organise our pharma business into three segments. Firstly, ‘Specialty Pharmaceuticals’ comprising Radiopharmaceuticals (including Radiopharmacies) and Allergy Therapy Products. Secondly, our ‘CDMO’ segment, comprising Parenteral Contract Manufacturing and Active Pharmaceutical Ingredients. Finally, the ‘Generics’ segment is for our Finished Dosage Formulations business.

We supply our products and services to customers in over 85 countries. We have four manufacturing facilities in North America and two in India, coupled with research and development centers in North America and India. Additionally, we have a distribution network of more than 45 radiopharmacies in the United States.

To find out more about Jubilant Pharma Limited, please click here.

Jubilant Pharmova Limited

Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with global presence that is involved in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation (CRDMO), Generics and Proprietary Novel Drugs businesses.

In the Radiopharma business, the Company is involved in manufacturing and supply of Radiopharmaceuticals with a network of 46 radio-pharmacies in the US. The Company’s Allergy Immunotherapy business is involved in the manufacturing and supply of allergic extracts and venom products in the US and in some other markets such as Canada, Europe and Australia. Jubilant through its CDMO Sterile Injectables business offers manufacturing services including sterile fill and finish injectables (both liquid and lyophilization), full-service ophthalmic offer (liquids, ointments & creams) and ampoules.

To find out more about Jubilant Pharmova Limited, please click here.


We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.